Uncategorized

INOVIQ (ASX:IIQ) has announced excellent results from an independent clinical validation study of the company’s SubB2M/CA15-3 test for breast cancer detection. CEO Dr Leearne Hinch said: “Our blood test detected all-stages of breast cancer with 81% sensitivity and 93% specificity, outperforming a leading CA15-3 test.” Shares are trading 19 per cent higher at 60 cents. […]

Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses promising results in the company’s lead therapy for glioblastoma, and the timeline for the recently launched Phase 1b trial. Tim McGowen: Today we’re talking with Chimeric Therapeutics (ASX:CHM). Market cap of around $16m. We have with us the CEO and Managing Director, Jennifer Chow.

27 Jun 2023 – The Nasdaq Composite slumped on Monday as investors sold shares of outperforming tech companies and the final trading week of the first half commenced.

The Nasdaq Composite slumped on Monday as investors sold shares of technology companies that have outperformed this year and the final trading week of the first half commenced. The Nasdaq shed 1.16 per cent to settle at 13,335.78, while the S&P 500 lost 0.45 per cent to close at 4,328.82. The Dow Jones Industrial Average

Metcash (ASX:MTS) may have reported record annual sales and earnings for the year ending 30 April, but closer examination of the results reveals warning signs that cast doubt on the initial 9% surge in the retailer’s share price on Monday. By mid-afternoon, the early bounce had halved to just over 4% as investors scrutinized the

Shares in Element 25 (ASX:E25), a prominent manganese miner and explorer, experienced a significant surge of 23% on Monday following the announcement of a momentous supply contract with the renowned US car manufacturer, General Motors (GM). The contract, anticipated to be a multi-million dollar agreement, marks a substantial milestone in a project with an estimated

Musgrave Minerals (ASX:MGV)’s board has unanimously advised shareholders to decline the all-stock bid presented by Westgold Resources (ASX:WGX), asserting that the offer undervalues the company and fails to account for its growth potential. The bid, which implies a value of $177.3 million, offers Musgrave shareholders one share in Westgold for every 5.37 Musgrave shares. In

After telling the world that it would be disciplined in spending capital, Wesfarmers (ASX:WES) has surprised the market by announcing its decision to match the $3.35 per share offer made by Hong Kong-based EC Healthcare for SILK Laser (ASX:SLA). This move comes after Wesfarmers’ API was outbid by EC Healthcare in May, when they presented

The Australian dollar is currently trading near its lowest level since the beginning of June due to concerns among investors about central banks increasing policy interest rates. There is a widespread belief that these rate hikes will negatively impact the global economy, commodity prices, and the Australian dollar (AUD). Commonwealth Bank analysts predict that the